Mathie P.G. Leers

2.9k total citations · 1 hit paper
92 papers, 2.1k citations indexed

About

Mathie P.G. Leers is a scholar working on Oncology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Mathie P.G. Leers has authored 92 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 23 papers in Molecular Biology and 18 papers in Infectious Diseases. Recurrent topics in Mathie P.G. Leers's work include Cancer Cells and Metastasis (15 papers), Acute Myeloid Leukemia Research (10 papers) and COVID-19 Clinical Research Studies (10 papers). Mathie P.G. Leers is often cited by papers focused on Cancer Cells and Metastasis (15 papers), Acute Myeloid Leukemia Research (10 papers) and COVID-19 Clinical Research Studies (10 papers). Mathie P.G. Leers collaborates with scholars based in Netherlands, Germany and United States. Mathie P.G. Leers's co-authors include Marius Nap, Frans C. S. Ramaekers, Bert Schutte, P Theunissen, Gordon Tribbick, Bengt Persson, Tomas Bergman, E.C.M. Bollen, Paul H.M.H. Theunissen and Viveka Björklund and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Mathie P.G. Leers

87 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis

1999 564 citations Mathie P.G. Leers, Frans C. S. Ramaekers et al. profile →

Peers

Countries citing papers authored by Mathie P.G. Leers

Since Specialization

Citations

This map shows the geographic impact of Mathie P.G. Leers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathie P.G. Leers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathie P.G. Leers more than expected).

Fields of papers citing papers by Mathie P.G. Leers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathie P.G. Leers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathie P.G. Leers. The network helps show where Mathie P.G. Leers may publish in the future.

Co-authorship network of co-authors of Mathie P.G. Leers

This figure shows the co-authorship network connecting the top 25 collaborators of Mathie P.G. Leers. A scholar is included among the top collaborators of Mathie P.G. Leers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathie P.G. Leers. Mathie P.G. Leers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development and validation of a risk prediction model for hospital admission in COVID-19 patients presenting to primary care 2024 ·European Journal of General Practice ·Laure Wynants, Natascha J.H. Broers, (unknown), Roderick P Venekamp, Dennis G. Barten, Mathie P.G. Leers, Theo Verheij, Patricia M. Stassen, Jochen Cals, Eefje de Bont	2
2	Advancing COVID-19 diagnostics: rapid detection of intact SARS-CoV-2 using viability RT-PCR assay 2024 ·Microbiology Spectrum ·(unknown), (unknown), Inge H. M. van Loo, Bart L. Haagmans, Mathie P.G. Leers, Mart M. Lamers, Mayk Lucchesi, Bas C. T. van Bussel, Walther van Mook, Rudy M.M.A. Nuijts, Paul H. M. Savelkoul, Mor M. Dickman, Petra Wolffs	5
3	External Quality Assessment on Molecular Tumor Profiling with Circulating Tumor DNA-Based Methodologies Routinely Used in Clinical Pathology within the COIN Consortium 2024 ·Clinical Chemistry ·Paul van der Leest, (unknown), John W. J. Hinrichs, Carel J.M. van Noesel, Karen Zwaenepoel, Birgit Deiman, (unknown), Ronald van Eijk, Ernst‐Jan M. Speel, (unknown), Marjolijn J. L. Ligtenberg, (unknown), Maurice P.H.M. Jansen, Hendrikus J. Dubbink, (unknown), Mathie P.G. Leers, Menno Tamminga, Daan van den Broek, Léon C.L.T. van Kempen, Ed Schuuring	1
4	Early therapeutic drug monitoring helps to identify inflammatory bowel disease patients with a high risk to fail thiopurine treatment 2024 ·British Journal of Clinical Pharmacology ·(unknown), Björn Winkens, (unknown), (unknown), Paul Bus, Marieke Pierik, Melek Simsek, Nanne K.H. de Boer, Mathie P.G. Leers, Dennis R. Wong, Adriaan A. van Bodegraven	0
5	Vitamin insufficiency after surgery for oesophagogastric neoplasms: a study protocol for a prospective intervention study 2023 ·BMJ Open ·(unknown), (unknown), Evert-Jan G. Boerma, (unknown), Jan H.M.B. Stoot, Mathie P.G. Leers, Meindert N. Sosef, Guy H. E. J. Vijgen	2
6	Validating a clinical laboratory parameter-based deisolation algorithm for patients with COVID-19 in the intensive care unit using viability PCR: the CoLaIC multicentre cohort study protocol 2023 ·BMJ Open ·(unknown), Bas C. T. van Bussel, Stefan H. M. Gorissen, Inge H. M. van Loo, (unknown), Wilhelmine P.H.G. Verboeket‐van de Venne, Petra Wolffs, (unknown), Mathie P.G. Leers	0
7	Development and validation of an early warning score to identify COVID-19 in the emergency department based on routine laboratory tests: a multicentre case–control study 2022 ·BMJ Open ·Arjen‐Kars Boer, (unknown), (unknown), Heidi Ammerlaan, (unknown), (unknown), (unknown), Mathie P.G. Leers, Remy J.H. Martens, Madelon M. Buijs, (unknown), (unknown), (unknown), N.A.W. van Riel, Volkher Scharnhorst	2
8	Dutch National Round Robin Trial on Plasma-Derived Circulating Cell-Free DNA Extraction Methods Routinely Used in Clinical Pathology for Molecular Tumor Profiling 2022 ·Clinical Chemistry ·Paul van der Leest, (unknown), Carel J.M. van Noesel, Daan van den Broek, (unknown), Birgit Deiman, (unknown), Robert van der Geize, (unknown), Ernst‐Jan M. Speel, Maartje J. Geerlings, (unknown), Maurice P.H.M. Jansen, (unknown), Else Driehuis, Mathie P.G. Leers, Grigory Sidorenkov, Menno Tamminga, Léon C.L.T. van Kempen, Ed Schuuring	18
9	Opschalen naar een bovenregionale 24/7-HAP bij de COVID-19-pandemie 2022 ·Huisarts en Wetenschap ·Eefje de Bont, Natascha J.H. Broers, Dennis M.J. Muris, Laure Wynants, Mathie P.G. Leers, (unknown), Jochen Cals, Siamack Sabrkhany, (unknown), (unknown), (unknown), (unknown)	1
10	A novel multiparameter flow cytometric assay for inosine triphosphatase expression analysis in leukocytes 2012 ·Cytometry Part A ·(unknown), Imke C.A. Munnix, Jaap Bakker, Jörgen Bierau, (unknown), Mathie P.G. Leers	3
11	The transferrin/log(ferritin) ratio: a new tool for the diagnosis of iron deficiency anemia 2012 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·(unknown), (unknown), (unknown), Mathie P.G. Leers, Ruud Beukers, Mark‐David Levin, Pieter Sonneveld, (unknown)	26
12	Circulating PSA-Containing Macrophages as a Possible Target for the Detection of Prostate Cancer 2008 ·American Journal of Clinical Pathology ·Mathie P.G. Leers, Marius Nap, Ralf Herwig, K.P.J. Delaere, Frans Nauwelaers	15
13	Differentiating transudative from exudative pleural effusion: should we measure effusion cholesterol dehydrogenase? 2007 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Mathie P.G. Leers, Henne A. Kleinveld, Volkher Scharnhorst	15
14	Prostatakarzinomscreening durch einen neuen Marker auf der Basis zirkulierender Blutmakrophagen? 2007 ·Der Urologe ·Ralf Herwig, Bob Djavan, Gero Kramer, Moustafa A. El Taieb, (unknown), Mathie P.G. Leers, Michael Marberger	1
15	Effects of a long-distance run on cardiac markers in healthy athletes 2006 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Mathie P.G. Leers, (unknown), Ruben Baumgarten	52
16	Keratin 8/18 breakdown and reorganization during apoptosis 2004 ·Experimental Cell Research ·Bert Schutte, Mieke E.R. Henfling, Wendy Kölgen, (unknown), Steven J.R. Meex, Mathie P.G. Leers, Marius Nap, Viveka Björklund, (unknown), Bertil Björklund, E. Birgitte Lane, M. Bishr Omary, Hans Jörnvall, Frans C. S. Ramaekers	171
17	Her2/neu analysis in formalin-fixed, paraffin-embedded breast carcinomas: comparison of immunohistochemistry and multiparameter DNA flow cytometry. 2003 ·PubMed ·Mathie P.G. Leers, (unknown), Marius Nap	7
18	Reduced E-Cadherin Expression Is Associated with Increased Lymph Node Metastasis and Unfavorable Prognosis in Non-small Cell Lung Cancer 1998 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Mathie P.G. Leers, J.A. van Noord, E.C.M. Bollen, Paul H.M.H. Theunissen	117
19	Multi-parameter flow cytometric analysis with detection of the Ki67-Ag in paraffin embedded mammary carcinomas 1997 ·Cytometry ·Mathie P.G. Leers, P Theunissen, Frans C. S. Ramaekers, B. Schütte	16
20	Trivariate flow cytometric analysis of paraffin-embedded lung cancer specimens: Application of cytokeratin subtype specific antibodies to distinguish between differentiation pathways 1997 ·Cytometry ·Mathie P.G. Leers, Paul H.M.H. Theunissen, J Koudstaal, Bert Schutte, Frans C. S. Ramaekers	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact